Revenue: The sum of all revenue fields included for a company's operating activities.
Avadel Pharmaceuticals PLC. (AVDL) had Revenue of $52.51M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$52.51M |
$-4.92M |
|
$5.58M |
|
$46.93M |
|
$55.51M |
|
$-3.00M |
|
$-1.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.92M |
|
$-4.92M |
|
$-4.92M |
|
$-4.92M |
|
$-3.00M |
|
$-2.18M |
|
96.60M |
|
96.60M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$139.26M |
|
$0.31M |
|
$28.69M |
|
$167.95M |
|
$50.93M |
|
-- |
|
$42.95M |
|
$93.88M |
|
$74.07M |
|
$57.23M |
|
$74.07M |
|
96.63M |
|
| Cash Flow Statement Financials | |
$-8.23M |
|
$12.32M |
|
$0.69M |
|
$51.37M |
|
$56.37M |
|
$5.00M |
|
$4.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.38% |
|
-5.71% |
|
-5.71% |
|
-- |
|
-9.22% |
|
-9.37% |
|
$-8.23M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
0.27 |
|
1.26 |
|
71.27 |
|
-6.64% |
|
-8.60% |
|
-2.93% |
|
-6.64% |
|
$0.77 |
|
$-0.09 |
|
$-0.09 |
|